PharmCo III ApS Financials, key figures and credit report
Gross profit -33.0 kDKK FY 2025 -6.5% vs 2024
EBIT -33.0 kDKK FY 2025 -6.5% vs 2024
Net debt -1 233.0 kDKK FY 2025 -119.8% vs 2024
Quick ratio 16.9 FY 2025 +16.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | -29.17 | -31.00 | -33.00 | ||
| Gross profit | -26.16 | -27.10 | -29.17 | -31.00 | -33.00 |
| EBIT | -26.16 | -27.10 | -29.17 | -31.00 | -33.00 |
| Other financial income | 0.11 | 232.00 | 249.00 | ||
| Other financial expenses | - 841.05 | - 661.11 | -1 230.72 | -1 088.00 | - 250.00 |
| Net income from associates (fin.) | 21 391.50 | 12 830.40 | 12 319.30 | 14 765.00 | 18 566.00 |
| Pre-tax profit | 20 524.28 | 12 142.20 | 11 059.52 | 13 878.00 | 18 532.00 |
| Net earnings | 20 524.28 | 12 142.20 | 11 059.52 | 13 878.00 | 18 532.00 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 96 225.38 | 90 991.52 | 82 045.65 | 79 452.00 | 95 983.00 |
| Investments total | 96 225.38 | 90 991.52 | 82 045.65 | 79 452.00 | 95 983.00 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current owed by particip. interest comp. | 5 250.00 | 5 481.00 | 3 776.00 | ||
| Short term receivables total | 5 250.00 | 5 481.00 | 3 776.00 | ||
| Cash and bank deposits | 39.10 | 37.99 | 37.30 | 36.00 | 1 233.00 |
| Cash and cash equivalents | 39.10 | 37.99 | 37.30 | 36.00 | 1 233.00 |
| Balance sheet total (assets) | 96 264.48 | 91 029.51 | 87 332.95 | 84 969.00 | 100 992.00 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | 18 462.97 | 38 422.99 | 50 300.01 | 61 501.00 | 82 124.00 |
| Profit of the financial year | 20 524.28 | 12 142.20 | 11 059.52 | 13 878.00 | 18 532.00 |
| Shareholders equity total | 39 027.25 | 50 605.19 | 61 399.53 | 75 419.00 | 100 696.00 |
| Non-current owed to group member | 5 591.62 | 5 804.61 | 6 034.47 | ||
| Non-current liabilities total | 5 591.62 | 5 804.61 | 6 034.47 | ||
| Current trade creditors | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 |
| Current owed to participating | 6 273.00 | ||||
| Other non-interest bearing current liabilities | 51 630.61 | 34 604.71 | 19 883.95 | 3 262.00 | 281.00 |
| Current liabilities total | 51 645.61 | 34 619.71 | 19 898.95 | 9 550.00 | 296.00 |
| Balance sheet total (liabilities) | 96 264.48 | 91 029.51 | 87 332.95 | 84 969.00 | 100 992.00 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated